Aspirin for the primary prevention of cardiovascular events: recommendation and rationale
- PMID: 11790071
- DOI: 10.7326/0003-4819-136-2-200201150-00015
Aspirin for the primary prevention of cardiovascular events: recommendation and rationale
Abstract
This statement summarizes the recommendation of the third U.S. Preventive Services Task Force (USPSTF) for aspirin for the primary prevention of cardiovascular events, as well as the supporting scientific evidence. The complete information on which this statement is based, including evidence tables and references, can be found in a companion article in this issue. Copies of this document, the summary of the evidence, and the systematic evidence review can be obtained through the USPSTF Web site (http://www.ahrq.gov/clinic/uspstfix.htm) and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (800-358-9295).
Comment in
-
Aspirin for the primary prevention of cardiovascular events.Ann Intern Med. 2002 Oct 1;137(7):622-3. doi: 10.7326/0003-4819-137-7-200210010-00024. Ann Intern Med. 2002. PMID: 12353960 No abstract available.
Summary for patients in
-
Summaries for patients. Aspirin for the prevention of heart attacks in people without previous cardiovascular events: recommendations from the United States Preventive Services Task Force.Ann Intern Med. 2002 Jan 15;136(2):I55. doi: 10.7326/0003-4819-136-2-200201150-00005. Ann Intern Med. 2002. PMID: 11928737 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical